24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Teva
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
20:31
Israel tests Arrow missile as Iran threat drives next generation upgrades
19:44
Taboola loses a quarter of its value as slowing growth overshadows profit turnaround
16:53
"Groundwater could flood hundreds of high-rise buildings in coastal cities"
16:36
Founders keep asking me if this is a bubble. That's the wrong question.
More stories
Buzz
Most popular
Daily
Weekly
1
Billionaire Beny Steinmetz challenges $1.4 million tax demand over $9 million Israeli home sale
2
Salesforce veterans raise $20 million pre-Seed from Marc Benioff and Michael Dell to tackle AI’s enterprise bottleneck
3
Wix's Base44 bet comes at a price as losses widen to $76.4 million
4
25-year-old AI investor’s $16 billion bet hits a brutal reality check
5
Monday seeks to double CEO pay weeks after announcing 620 layoffs
More news
Teva
12 stories about Teva
Teva Sells IUD Business for $1.1 Billion
12.09.17
|
Lilach Baumer
Going forward, the company will focus on central nervous system and respiratory treatments, shedding its Women's Health and Oncology and Pain businesses
New CEO to Break Teva’s Copaxone Habit
11.09.17
|
Sophie Shulman, Dror Reich
Troubled drugmaker says new CEO must work to quickly regain its financial credibility
Teva Appoints Lundbeck's Schultz as CEO
11.09.17
|
Dror Reich and Micky Grunfeld
The company’s announcement brings an end to a seven month search for a CEO to lead the troubled generic drugmaker. Updated
Bidders Line Up for Teva’s Women Health Unit, Report Says
23.08.17
|
Dror Reich
Church & Dwight Co. and Cooper Companies Inc. join other bidders for troubled drugmaker assets, Bloomberg reported Tuesday
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies
Cerberus, Advent Eye Teva's European Assets, Report Says
15.08.17
|
Calcalist
The private equity firms are taking an interest in Teva's European oncology and pain treatment assets, estimated at $700 million to 1$ billion, according to a Bloomberg report
Allergan Sketches Road Show to Sell Teva Stake
14.08.17
|
Golan Hazani
The company is in discussions with investment bankers and brokers to sell its Teva shares, said one person familiar with the matter
With Bloated Debt, Teva Looks to Sell Assets
10.08.17
|
Eli Shimony and Gil Kalian
The generic drugmaker said it is looking to sell Medis, an Iceland-based company it bought in 2016
Teva’s Perfect Storm Sends Tel-Aviv Stock Exchange Down
06.08.17
|
Calcalist
Teva’s stock price dropped sharply on Thursday and Friday after the company released quarterly revenue and profits that fell short of analysts’ forecasts
Soriot's Teva Appointment Unlikely, Says Activist Investor
06.08.17
|
Golan Hazani
Teva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"
Allergan Can Now Sell 9.8% Teva Stake
03.08.17
|
Dror Reich
Yesterday, a lock-up period on $3.2 billion worth Teva Pharmaceutical Industries’ shares owned by Allergan ended
Teva in Talks to Appoint AstraZenca's Pascal Soriot as CEO
18.07.17
|
Golan Hazani
Mr. Soriot has met with the company’s search committee and its chairman and expressed his agreement to serve as its next CEO, people familiar with the matter said
Previous Articles